Estabrook Capital Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.7K | Sell |
185
-16
| -8% | -$1.54K | ﹤0.01% | 260 |
|
|
2026
Q1 | $20.8K | Buy |
201
+16
| +9% | +$1.81K | ﹤0.01% | 240 |
|
|
2025
Q4 | $18.7K | Hold |
185
| – | – | ﹤0.01% | 238 |
|
|
2025
Q3 | $22.8K | Hold |
185
| – | – | ﹤0.01% | 232 |
|
|
2025
Q2 | $22.2K | Hold |
185
| – | – | ﹤0.01% | 231 |
|
|
2025
Q1 | $27.2K | Hold |
185
| – | – | ﹤0.01% | 213 |
|
|
2024
Q4 | $30K | Hold |
185
| – | – | ﹤0.01% | 216 |
|
|
2024
Q3 | $30.1K | Hold |
185
| – | – | ﹤0.01% | 222 |
|
|
2024
Q2 | $25.2K | Hold |
185
| – | – | ﹤0.01% | 228 |
|
|
2024
Q1 | $28.3K | Hold |
185
| – | – | ﹤0.01% | 235 |
|
|
2023
Q4 | $26.4K | Hold |
185
| – | – | ﹤0.01% | 235 |
|
|
2023
Q3 | $24.2K | Hold |
185
| – | – | ﹤0.01% | 241 |
|
|
2023
Q2 | $29.4K | Hold |
185
| – | – | ﹤0.01% | 240 |
|
|
2023
Q1 | $29.3K | Hold |
185
| – | – | 0.01% | 242 |
|
|
2022
Q4 | $26K | Hold |
185
| – | – | ﹤0.01% | 252 |
|
|
2022
Q3 | $23.8K | Hold |
185
| – | – | ﹤0.01% | 253 |
|
|
2022
Q2 | $26.1K | Hold |
185
| – | – | ﹤0.01% | 263 |
|
|
2022
Q1 | $25.7K | Hold |
185
| – | – | ﹤0.01% | 264 |
|
|
2021
Q4 | $32.3K | Hold |
185
| – | – | ﹤0.01% | 260 |
|
|
2021
Q3 | $30.6K | Hold |
185
| – | – | ﹤0.01% | 217 |
|
|
2021
Q2 | $33.3K | Hold |
185
| – | – | 0.01% | 225 |
|
|
2021
Q1 | $35.7K | Hold |
185
| – | – | 0.01% | 224 |
|
|
2020
Q4 | $37.4K | Hold |
185
| – | – | 0.01% | 221 |
|
|
2020
Q3 | $38.9K | Hold |
185
| – | – | 0.01% | 207 |
|
|
2020
Q2 | $40.6K | Hold |
185
| – | – | 0.01% | 204 |
|
|
2020
Q1 | $32.1K | Hold |
185
| – | – | 0.01% | 211 |
|
|
2019
Q4 | $28.4K | Sell |
185
-86
| -32% | -$12.9K | ﹤0.01% | 240 |
|
|
2019
Q3 | $41.2K | Buy |
271
+86
| +46% | +$13.6K | 0.01% | 216 |
|
|
2019
Q2 | $28.3K | Hold |
185
| – | – | ﹤0.01% | 242 |
|
|
2019
Q1 | $29.7K | Hold |
185
| – | – | ﹤0.01% | 238 |
|
|
2018
Q4 | $28.5K | Hold |
185
| – | – | 0.01% | 232 |
|
|
2018
Q3 | $27.8K | Hold |
185
| – | – | ﹤0.01% | 255 |
|
|
2018
Q2 | $25K | Hold |
185
| – | – | ﹤0.01% | 268 |
|
|
2018
Q1 | $24.6K | Hold |
185
| – | – | ﹤0.01% | 279 |
|
|
2017
Q4 | $27.5K | Hold |
185
| – | – | ﹤0.01% | 272 |
|
|
2017
Q3 | $24.4K | Hold |
185
| – | – | ﹤0.01% | 294 |
|
|
2017
Q2 | $24.6K | Hold |
185
| – | – | ﹤0.01% | 290 |
|
|
2017
Q1 | $24.9K | Hold |
185
| – | – | ﹤0.01% | 296 |
|
|
2016
Q4 | $22.2K | Hold |
185
| – | – | ﹤0.01% | 305 |
|
|
2016
Q3 | $23.2K | Hold |
185
| – | – | ﹤0.01% | 303 |
|
|
2016
Q2 | $25.6K | Hold |
185
| – | – | ﹤0.01% | 298 |
|
|
2016
Q1 | $23.3K | Hold |
185
| – | – | ﹤0.01% | 295 |
|
|
2015
Q4 | $23.5K | Hold |
185
| – | – | ﹤0.01% | 303 |
|
|
2015
Q3 | $21.4K | Buy |
+185
| New | +$20.8K | ﹤0.01% | 308 |
|
Other funds holding CLX
Estabrook Capital Management's CLX Position: Q2 2026 in Review
Estabrook Capital Management reduced its Clorox (CLX) stake by 8% in Q2 2026, selling an estimated $1.54K and leaving 185 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #260.
Estabrook Capital Management first reported a position in CLX in Q3 2015 and has held it in 44 quarters since. The position peaked at $41.2K in Q3 2019. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Estabrook Capital Management held 185 shares of Clorox worth $17.7K as of Q2 2026.
- Estabrook Capital Management sold 16 Clorox shares in Q2 2026, an estimated $1.54K.
- Clorox made up ﹤0.01% of Estabrook Capital Management's portfolio in Q2 2026, its #260 holding.
- Estabrook Capital Management first reported a position in Clorox in Q3 2015 and has held it in 44 quarters since.
- Estabrook Capital Management's Clorox position peaked at $41.2K in Q3 2019.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Estabrook Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.